Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Dr Georg Kranz
With
Chinese University of Hong Kong
Prince of Wales Hospital, Shatin, Hong Kong
Kowloon Hospital, Hong Kong
Please refer to the full proposal
Age
18–60
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
MDD group:
MDD (DSM-5), HAMD17 ≥18, approval for TBS treatment by the physician in charge, stable antidepressive medication 4 weeks before treatment (the sample will include at least 20 drug-naïve patients in order to avoid confounding effects of medication for testing hypothesis 4).
age between 18 and 60, right-handedness.
You may not be if
a history of brain surgery, head injury, stroke or neurodegenerative disorder, diagnosis of personality disorder, psychotic features, active suicidal intent, severe somatic comorbidities, cardiac pacemakers, deep brain stimulation, intracranial metallic particles, history of seizures, antiepileptics and benzodiazepines corresponding to a dose of \>1 mg lorazepam/d, substance dependence or abuse, if it is the primary clinical problem.
HC group:
a current or previous diagnosis of a psychiatric, neurological disorder or severe internal illness, common contraindications to rTMS,26 and a psychiatric disorder in their first-degree relatives.
Clareo Health | The Utility of Concurrent TBS/fNIRS for Antidepressant Treatment Optimization
